Platelet and Plasma Market to Hit $7.1B by 2026: Global Market Insights, Inc.

Some of the major platelet & plasma market participants include America's Blood Centers, American Association of Blood Banks, American Red Cross, European Blood Alliance, Indian Red Cross, Blood Centers of America, Japanese Red Cross, South African Red Cross Society, Italian Red Cross and OneBlood.

SELBYVILLE, Del. - June 25, 2020 - (

​Global Market Insights, Inc. has recently added a new report on the platelet and plasma market which estimates the market valuation for platelets & plasma will cross US $7.1 billion by 2026. Favorable government initiatives to encourage blood donation among individuals will foster the overall market growth.

The increasing prevalence of liver diseases among the elderly population, owing to functional limitations, will favor market growth. Rising cases of liver cirrhosis, alcohol-related liver disease, non-alcoholic steatohepatitis, liver cancer, pediatric liver disease, hepatocellular carcinoma among others will propel the platelet and plasma market during the forecast period. According to the American Liver Foundation, about 21,000 men and 8,000 women are affected by liver cancer each year in the U.S. Thus, increasing cases of liver associated disorders across the globe will augment the platelet & plasma industry growth.

Request a sample of this research report at

The plasma segment accounted for over 33% of the market share in 2019. Plasma can be used for the treatment of various diseases. Usage of plasma for individuals suffering from a burn, shock, along with liver disease and multiple clotting factor deficiencies will favor the segmental growth. The increasing prevalence of chronic and neurological diseases requiring plasma for treatment will augment the segmental progression.

The hemorrhage segment is expected to account for around a 2% CAGR during 2020-2026. Hemorrhage refers to abnormal blood loss inside and outside the body. Postpartum hemorrhage (PPH) refers to a heavy loss of blood post-pregnancy. According to the World Health Organization (WHO), postpartum hemorrhage is one of the leading causes of maternal mortality in low-income countries. The demand for platelets and plasma for treatment of hemorrhage, especially postpartum hemorrhage, will propel the segmental growth.

The hospital segment accounted for around a 62% market share in 2019. The rising number of hospital visits for the treatment of several health-related issues propels the overall market growth. The availability of blood transfusions in hospitals for the treatment of chronic diseases, such as cancer, diabetes, epilepsy, heart disease among others, will boost the segmental growth. The availability of advanced healthcare technologies and facilities, as well as reimbursement policies for hospital treatment, will foster market growth.

Browse key industry insights spread across 110 pages with 83 market data tables and eight figures and charts from the report, "Platelet and Plasma Market Share & Forecast, 2020 - 2026" in detail, along with the table of contents:

The Asia-Pacific platelet & plasma market accounted for over USD 1.7 Billion market value in 2019 and is projected to experience substantial growth during the analysis period. Developing healthcare infrastructure will lead to a rise in plasma and platelet demand. Moreover, surging initiatives by several organizations such as the Indian Red Cross Society to create awareness for blood donation will foster the Asia-Pacific's market growth.

Some major findings of the platelet and plasma market report include:

  • Increasing number of blood transfusions will favor the platelet and plasma market growth.
  • Advances in therapeutic protein drug development, along with rising demand for advanced therapies for the treatment of several diseases, will augment the market growth globally.
  • Exclusive use of plasma for the treatment of rare diseases in Europe will accelerate the platelet & plasma market growth.
  • Favorable reimbursement scenario in developed countries will enhance the platelet and plasma business growth.
  • Increasing funds for the improvement of blood storage infrastructure in North America promotes the regional industry growth.

Some of the prominent business players operating in the platelet & plasma industry include America's Blood Centers, American Association of Blood Banks, American Red Cross, European Blood Alliance, Indian Red Cross, Blood Centers of America, Japanese Red Cross, South African Red Cross Society, Italian Red Cross, and OneBlood. These market players are focusing on developing innovative services to encourage blood donation. For instance, in April 2018, American Red Cross relaunched to make donations more convenient for donors through improved content search, mobile-friendly user experience, and advanced personalization. The launch helped the organization to attract more donors, thereby securing the company's growth.

Browse complete report table of contents @

Partial chapters of report table of contents (TOC):

Chapter 2. Executive Summary

2.1. Platelet and plasma industry 360⁰ synopsis, 2015 - 2026

2.1.1. Business trends

2.1.2. Component trends

2.1.3. Application trends

2.1.4. Distribution channel trends

2.1.5. Regional trends

Chapter 3. Platelet and Plasma Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry ecosystem

3.3.1. Value chain analysis

3.3.2. Distribution channel analysis

3.4. Industry impact forces

3.4.1. Growth drivers Higher number of blood transfusions in Europe Recent advances in therapeutic protein drug development Increasing prevalence of liver diseases in elderly population Exclusive use of plasma for treatment of rare diseases in Europe Fair reimbursement in developed countries

3.4.2. Industry pitfalls & challenges Stringent regulatory policies Affordability issue in APAC and Latin America due to high costs

3.5. Growth potential analysis

3.5.1. By component

3.5.2. By application

3.5.3. By distribution channel

3.6. COVID-19 impact analysis

3.7. Porter's analysis

3.8. PESTEL analysis

Browse related report:

Blood Preparation Market Size By Product (Blood and Blood Components {Whole Blood, Blood Components [Red Blood Cells, Platelets, Plasma, White Blood Cells]}, Anti-thrombotic and Anticoagulants {Platelet Aggregation Inhibitors [Glycoprotein Inhibitors, COX Inhibitors, ADP Antagonists, Phosphodiesterase Inhibitors], Fibrinolytics, Anticoagulants [Heparins {Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin}, Vitamin K Antagonists, Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

Related Links
Healthcare & Medical Devices Industry Insights
Blood Gas and Electrolyte Analyzers Market

Press Release Service by

Original Source: Platelet and Plasma Market to Hit $7.1B by 2026: Global Market Insights, Inc.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.